Published in Nephron Clin Pract on June 19, 2006
Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Pediatr Nephrol (2013) 1.60
Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS. Pediatr Nephrol (2007) 0.84
Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults. Kidney Int Suppl (2011) (2012) 0.83
Focal segmental glomerulosclerosis--does treatment work? Nephron Clin Pract (2006) 0.79
Collapsing focal segmental glomerulosclerosis: Current concepts. World J Nephrol (2012) 0.78
Citral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in mice. PLoS One (2013) 0.77
Corticosteroids vs. corticosteroids plus cycloporin A in adult minimal changes disease. BMC Res Notes (2009) 0.75
Calcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature. Can J Kidney Health Dis (2017) 0.75
Rethinking First-Line Immunosuppression for Idiopathic FSGS. Clin J Am Soc Nephrol (2016) 0.75
Treatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two Decades. Biomed Res Int (2016) 0.75
A novel multidrug therapy for difficult cyclosporine-resistant focal segmental glomerulosclerosis. Pediatr Nephrol (2008) 0.75
Optimal management of primary focal segmental glomerulosclerosis in adults. Int J Nephrol Renovasc Dis (2017) 0.75
Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: a prospective randomized study. Crit Care Med (2011) 3.12
The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. Am J Kidney Dis (2005) 2.57
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv (2012) 2.54
The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant (2009) 2.31
Effect of Angiotensin converting enzyme inhibitors on soluble tumor-necrosis-factor-related apoptosis-inducing ligand levels - association with neointimal hyperplasia in drug eluting stents. J Interv Cardiol (2014) 1.98
GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant (2005) 1.96
The burden of chronic kidney disease. BMJ (2006) 1.57
Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study. Nephron Clin Pract (2003) 1.45
Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol Dial Transplant (2006) 1.33
Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl (2005) 1.30
Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping. JACC Cardiovasc Interv (2011) 1.25
Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study. J Am Coll Cardiol (2012) 1.20
Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol (2003) 1.14
A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant (2002) 1.11
Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. J Am Soc Nephrol (2007) 1.05
Transglutaminase inhibition ameliorates experimental diabetic nephropathy. Kidney Int (2009) 1.03
Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron Clin Pract (2009) 1.03
Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant (2009) 1.03
Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells. J Biol Chem (2004) 1.02
Vascular calcifications in uremia: old concepts and new insights. Semin Dial (2006) 0.98
Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine. Transplantation (2007) 0.95
Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria. Nephrol Dial Transplant (2002) 0.95
Matrix metalloproteinases and their inhibitions in experimental renal scarring. Exp Nephrol (2002) 0.93
A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis. Kidney Int (2002) 0.93
Chronic kidney disease: stemming the global tide. Am J Kidney Dis (2005) 0.90
Differential effect of ticagrelor versus prasugrel on coronary blood flow velocity in patients with non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: an exploratory study. Circ Cardiovasc Interv (2013) 0.89
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with diabetes. Diabetes Care (2013) 0.89
An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy. Am J Physiol Renal Physiol (2005) 0.86
High prevalence of microalbuminuria in the overweight and obese population: data from a UK population screening programme. Nephron Clin Pract (2009) 0.86
Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed children. Pediatr Nephrol (2003) 0.84
Tissue transglutaminase: a mediator and predictor of chronic allograft nephropathy? Transplantation (2004) 0.84
Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI. J Am Coll Cardiol (2013) 0.83
Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy? Nephrol Dial Transplant (2010) 0.83
Effects of caspase inhibition on the progression of experimental glomerulonephritis. Kidney Int (2003) 0.82
Acute effect of sildenafil on central hemodynamics in mechanically ventilated patients with WHO group III pulmonary hypertension and right ventricular failure necessitating administration of dobutamine. Int J Cardiol (2012) 0.81
The heart seems to be the primary site and the target of anaphylaxis resulting in the development of Kounis syndrome. Intern Emerg Med (2012) 0.81
First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients. Lipids Health Dis (2013) 0.81
Mycophenolate mofetil and oral ulcerations. Transplantation (2004) 0.80
Changes in matrix metalloproteinases and their inhibitors in kidney transplant recipients. Exp Clin Transplant (2012) 0.80
Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting. Can J Cardiol (2011) 0.80
Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis. BMC Nephrol (2005) 0.80
(-)-Epigallocatechin 3-O-gallate (EGCG)-induced apoptosis in normal rat kidney interstitial fibroblast (NRK-49F) cells. J Toxicol Sci (2008) 0.80
Prognostic significance of coronary artery calcium in asymptomatic subjects with usual cardiovascular risk. Am Heart J (2003) 0.79
Beating heart replacement of the pulmonary valve in a patient with surgically corrected Tetralogy of Fallot. Hellenic J Cardiol (2006) 0.79
Transulnar compared with transradial artery approach as a default strategy for coronary procedures: a randomized trial. The Transulnar or Transradial Instead of Coronary Transfemoral Angiographies Study (the AURA of ARTEMIS Study). Circ Cardiovasc Interv (2013) 0.79
Prasugrel overcomes high on-clopidogrel platelet reactivity in chronic coronary artery disease patients more effectively than high dose (150 mg) clopidogrel. Am Heart J (2011) 0.79
CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention. Thromb Res (2011) 0.78
Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAX. Int J Cardiol (2011) 0.78
The prognostic value of frozen section preimplantation graft biopsy in the outcome of renal transplantation. Ren Fail (2010) 0.78
Therapeutic approach of patients with IgA nephropathy. Ren Fail (2004) 0.78
Apoptosis and myofibroblast expression in human glomerular disease: a possible link with transforming growth factor-beta-1. Nephron (2002) 0.78
Mechanisms of nonfatal acute myocardial infarction late after stent implantation: the relative impact of disease progression, stent restenosis, and stent thrombosis. Am Heart J (2010) 0.78
Simultaneous drug-eluting and bare-metal stent implantation: long-term clinical outcome and findings of clinically indicated coronary angiography. Clin Cardiol (2011) 0.78
Onset of antiplatelet action with high (100 mg) versus standard (60 mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study. Circ Cardiovasc Interv (2014) 0.77
Cytoskeletal protein expression and regenerative markers in schistosomal nephropathy. Nephrol Dial Transplant (2002) 0.77
A propensity score-based comparison of flat panel digital detector fluoroscopy versus digital cinefluoroscopy for coronary artery calcium detection. Hellenic J Cardiol (2012) 0.77
Morphological characteristics of culprit atheromatic plaque are associated with coronary flow after thrombolytic therapy: new implications of optical coherence tomography from a multicenter study. JACC Cardiovasc Interv (2010) 0.77
Stem cell factor and crescentic glomerulonephritis. Am J Kidney Dis (2003) 0.77
Factors affecting residual platelet aggregation in prasugrel treated patients. Curr Pharm Des (2013) 0.77
Cardiac mortality in {beta}-thalassemia major: resting but not dobutamine stress echocardiography predicts mortality among initially cardiac disease-free patients in a prospective 12-year study. Eur J Heart Fail (2009) 0.77
Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease. Growth Horm IGF Res (2008) 0.77
Cellular toxicity of catechin analogues containing gallate in opossum kidney proximal tubular (OK) cells. J Toxicol Sci (2004) 0.77
Predictors of high on-treatment platelet reactivity early after clopidogrel loading in ST-elevation myocardial infarction. Circ J (2012) 0.77
Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival. Hemodial Int (2009) 0.77
An unexpected cause of acute ST-elevation: an unconsciously swallowed sewing needle migrating to the heart. Int J Cardiol (2011) 0.76
Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia. Transplantation (2004) 0.76
Growth factors and apoptosis-related protein expression in human crescentic nephritis. Med Sci Monit (2008) 0.76
Interaction of endothelin-1 and nitric oxide pathways in human tubular epithelial cells under the influence of cyclosporine-A. Ren Fail (2010) 0.76
Evaluation of below-the-knee drug-eluting stents with frequency-domain optical coherence tomography: neointimal hyperplasia and neoatherosclerosis. J Endovasc Ther (2013) 0.76
Cyclosporine induces endothelin-1 mRNA synthesis and nitric oxide production in human proximal tubular epithelial cell cultures. Ren Fail (2009) 0.76
Intrinsic platelet reactivity and thrombus burden in patients with ST-elevation myocardial infarction. Thromb Res (2013) 0.76
Inhibitors directed towards caspase-1 and -3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosis. Nephron Exp Nephrol (2004) 0.76
Response to letter regarding article, "Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction". Circ Cardiovasc Interv (2013) 0.75
Combined etiology of anaphylactic cardiogenic shock: amiodarone, epinephrine, cardioverter defibrillator, left ventricular assist devices and the Kounis syndrome. Ann Card Anaesth (2015) 0.75
Commentary on: Feltracco P, Barbieri S, Galligioni H, Pasin L, Gaudio RM, Tommasi A, et al. A fatal case of anaphylactic shock during paragliding. J Forensic Sci 2012; doi: 10.1111/j.1556-4029.2012.02187.x [Epub ahead of print]. J Forensic Sci (2012) 0.75
Angiographic estimation of atherosclerotic disease burden in a coronary artery fed by collaterals: a potential pitfall in decision for revascularization. Vasc Health Risk Manag (2011) 0.75
Corticosteroids vs. corticosteroids plus cycloporin A in adult minimal changes disease. BMC Res Notes (2009) 0.75
Ad hoc percutaneous coronary intervention after in-laboratory high dose clopidogrel loading for clopidogrel-naive patients: safe for all? Am J Cardiol (2010) 0.75
Double-barrel stenting of distal left main stenosis in a patient with acute coronary syndrome: intravascular ultrasound and optical coherence tomography follow-up at six months. Can J Cardiol (2010) 0.75
Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy. Nephrology (Carlton) (2010) 0.75
NHS league tables are more spin than substance. BMJ (2002) 0.75
Platelet reactivity measurements reveal patient noncompliance during ticagrelor maintenance therapy. Can J Cardiol (2013) 0.75
Supernumerary umbilical vein in a hydropic neonate with hypertrophic cardiomyopathy. Fetal Pediatr Pathol (2011) 0.75
Evolving pattern of on-prasugrel and on-ticagrelor platelet reactivity over time in ST elevation myocardial infarction patients. Int J Cardiol (2013) 0.75
Pharmacodynamic effect of prasugrel 5 mg vs clopidogrel 150 mg in elderly patients with high on-clopidogrel platelet reactivity. Am Heart J (2012) 0.75
Expression of apoptosis-related proteins bcl-2 and bax along with transforming growth factor (TGF-beta1) in the kidney of patients with glomerulonephritides. Ren Fail (2004) 0.75
Prevalence of contraindications and conditions for precaution for prasugrel administration in a real world acute coronary syndrome population. J Thromb Thrombolysis (2011) 0.75
Long term outcome of routine early versus late transfer for coronary angiography following presumably successful thrombolysis for ST-segment elevation myocardial infarction. Int J Cardiol (2010) 0.75
Intimal hyperplasia by optical coherence tomography after BMS and DES implantation in the same artery. Int J Cardiol (2009) 0.75
Coronary calcium detected by digital cinefluoroscopy and coronary artery disease in patients undergoing coronary arteriography: effects of age and sex. Int J Cardiol (2003) 0.75
Cardiovascular magnetic resonance evaluation of patients with transposition of the great arteries following atrial switch surgical correction. Hellenic J Cardiol (2005) 0.75
Enzyme replacement therapy in severe Fabry disease with renal failure: a 1-year follow-up. Acta Derm Venereol (2004) 0.75
Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period. Ren Fail (2003) 0.75
ST-segment depression during vasodilator stress is of minor clinical importance in women with normal myocardial perfusion imaging and low or intermediate risk of coronary artery disease. Eur J Nucl Med Mol Imaging (2011) 0.75